Cargando…
CYB5D2 Requires Heme-Binding to Regulate HeLa Cell Growth and Confer Survival from Chemotherapeutic Agents
The cytochrome b5 domain containing 2 (CYB5D2; Neuferricin) protein has been reported to bind heme, however, the critical residues responsible for heme-binding are undefined. Furthermore, the relationship between heme-binding and CYB5D2-mediated intracellular functions remains unknown. Previous stud...
Autores principales: | Bruce, Anthony, Rybak, Adrian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899279/ https://www.ncbi.nlm.nih.gov/pubmed/24466094 http://dx.doi.org/10.1371/journal.pone.0086435 |
Ejemplares similares
-
Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle
por: Xie, Yanyun, et al.
Publicado: (2016) -
Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells
por: Aborehab, Nora M., et al.
Publicado: (2019) -
Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells
por: Zhang, Junmin, et al.
Publicado: (2021) -
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells
por: Gabellini, Nadia, et al.
Publicado: (2009) -
Electrolyte Metabolism in HeLa Cells
por: Wickson-ginzburg, Margaret, et al.
Publicado: (1963)